Janne Grønli1,2,3, William C Clegern1, Michelle A Schmidt1, Rahmi S Nemri1, Michael J Rempe2,4, Amelia L Gallitano5, Jonathan P Wisor1,2. 1. Elson S. Floyd College of Medicine, Department of Biomedical Sciences, Washington State University, Spokane, WA. 2. Sleep and Performance Research Center, Washington State University. 3. Department of Biological and Medical Psychology, University of Bergen, Norway. 4. Mathematics and Computer Science, Whitworth University, Spokane, WA. 5. Department of Basic Medical Sciences and Psychiatry, University of Arizona College of Medicine-Phoenix, Phoenix, AZ.
Abstract
STUDY OBJECTIVE: The expression of the immediate early gene early growth response 3 (Egr3) is a functional marker of brain activity including responses to novelty, sustained wakefulness, and sleep. We examined the role of this gene in regulating wakefulness and sleep. METHODS: Electroencephalogram/electromyogram (EEG/EMG) were recorded in Egr3-/- and wild-type (WT) mice during 24 h baseline, 6 h sleep disruption and 6 h recovery. Serotonergic signaling was assessed with 6 h EEG/EMG recordings after injections of nonselective 5-HT2 antagonist (clozapine), selective 5-HT2 antagonists (5-HT2A; MDL100907 and 5-HT2BC; SB206553) and a cocktail of both selective antagonists, administered in a randomized order to each animal. RESULTS: Egr3-/- mice did not exhibit abnormalities in the timing of wakefulness and slow wave sleep (SWS); however, EEG dynamics in SWS (suppressed 1-3 Hz power) and in quiet wakefulness (elevated 3-8 Hz and 15-35 Hz power) differed in comparison to WT-mice. Egr3-/- mice showed an exaggerated response to sleep disruption as measured by active wakefulness, but with a blunted increase in homeostatic sleep drive (elevated 1-4 Hz power) relative to WT-mice. Egr3-/-mice exhibit greatly reduced sedative effects of clozapine at the electroencephalographic level. In addition, clozapine induced a previously undescribed dissociated state (low amplitude, low frequency EEG and a stable, low muscle tone) lasting up to 2 h in WT-mice. Egr3-/- mice did not exhibit this phenomenon. Selective 5-HT2A antagonist, alone or in combination with selective 5-HT2BC antagonist, caused EEG slowing coincident with behavioral quiescence in WT-mice but not in Egr3-/- mice. CONCLUSION: Egr3 has an essential role in regulating cortical arousal, wakefulness, and sleep, presumably by its regulation of 5-HT2 receptors.
STUDY OBJECTIVE: The expression of the immediate early gene early growth response 3 (Egr3) is a functional marker of brain activity including responses to novelty, sustained wakefulness, and sleep. We examined the role of this gene in regulating wakefulness and sleep. METHODS: Electroencephalogram/electromyogram (EEG/EMG) were recorded in Egr3-/- and wild-type (WT) mice during 24 h baseline, 6 h sleep disruption and 6 h recovery. Serotonergic signaling was assessed with 6 h EEG/EMG recordings after injections of nonselective 5-HT2 antagonist (clozapine), selective 5-HT2 antagonists (5-HT2A; MDL100907 and 5-HT2BC; SB206553) and a cocktail of both selective antagonists, administered in a randomized order to each animal. RESULTS:Egr3-/- mice did not exhibit abnormalities in the timing of wakefulness and slow wave sleep (SWS); however, EEG dynamics in SWS (suppressed 1-3 Hz power) and in quiet wakefulness (elevated 3-8 Hz and 15-35 Hz power) differed in comparison to WT-mice. Egr3-/- mice showed an exaggerated response to sleep disruption as measured by active wakefulness, but with a blunted increase in homeostatic sleep drive (elevated 1-4 Hz power) relative to WT-mice. Egr3-/-mice exhibit greatly reduced sedative effects of clozapine at the electroencephalographic level. In addition, clozapine induced a previously undescribed dissociated state (low amplitude, low frequency EEG and a stable, low muscle tone) lasting up to 2 h in WT-mice. Egr3-/- mice did not exhibit this phenomenon. Selective 5-HT2A antagonist, alone or in combination with selective 5-HT2BC antagonist, caused EEG slowing coincident with behavioral quiescence in WT-mice but not in Egr3-/- mice. CONCLUSION:Egr3 has an essential role in regulating cortical arousal, wakefulness, and sleep, presumably by its regulation of 5-HT2 receptors.
Authors: A Gallitano-Mendel; Y Izumi; K Tokuda; C F Zorumski; M P Howell; L J Muglia; D F Wozniak; J Milbrandt Journal: Neuroscience Date: 2007-08-09 Impact factor: 3.590
Authors: G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley Journal: Neuron Date: 1995-02 Impact factor: 17.173
Authors: K J Aitchison; M W Jann; J H Zhao; T Sakai; H Zaher; K Wolff; D A Collier; R W Kerwin; F J Gonzalez Journal: J Psychopharmacol Date: 2000 Impact factor: 4.153
Authors: Lin Li; Sung Hwan Yun; James Keblesh; Barbara L Trommer; Huangui Xiong; Jelena Radulovic; Warren G Tourtellotte Journal: Mol Cell Neurosci Date: 2007-02-12 Impact factor: 4.314
Authors: Janne Grønli; Michael J Rempe; William C Clegern; Michelle Schmidt; Jonathan P Wisor Journal: J Sleep Res Date: 2016-01-30 Impact factor: 3.981
Authors: John H Harkness; Priyanka N Bushana; Ryan P Todd; William C Clegern; Barbara A Sorg; Jonathan P Wisor Journal: Sleep Date: 2019-01-01 Impact factor: 5.849